Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean Radiation Oncology Group-Reference-Cited by-同舟云学术

Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean Radiation Oncology Group

Published:2015-07-02 Issue:1 Volume:10 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Wee Chan Woo,Sung Wonmo,Kang Hyun-Cheol,Cho Kwan Ho,Han Tae Jin,Jeong Bae-Kwon,Jeong Jae-Uk,Kim Haeyoung,Kim In Ah,Kim Jin Hee,Kim Sung Hwan,Kim Suzy,Lee Dong Soo,Lee Me Yeon,Lim Do Hoon,Park Hye Li,Suh Chang-Ok,Yoon Sang Min,Kim Il Han

Funder

National Cancer Center Korea

Korean government

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-015-0439-z.pdf

Reference28 articles.

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.

2. Shapiro WR, Green SB, Burger PC, Mahaley Jr MS, Selker RG, VanGilder JC, et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg. 1989;71:1–9.